Page last updated: 2024-11-09

1-butyl-3-methylimidazolium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-butyl-3-methylimidazolium: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-butyl-3-methylimidazolium : A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is butyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2734162
CHEMBL ID1198608
CHEBI ID61333
SCHEMBL ID34968
MeSH IDM0517733

Synonyms (31)

Synonym
NCGC00166274-01
1-butyl-3-methyl-1h-imidazol-3-ium
[bmim]
[c4mim]
CHEBI:61333 ,
n-butyl-n'-methylimidazolium
1-butyl-3-methylimidazolium
1-butyl-3-methylimidazol-3-ium
NCGC00166274-02
NCGC00166274-04
NCGC00166274-03
CHEMBL1198608
80432-08-2
c4mim
unii-02n2g4u2ov
1h-imidazolium, 3-butyl-1-methyl-
1-methyl-3-butylimidazolium
02n2g4u2ov ,
butylmethylimidazolium [mi]
butylmethylimidazolium
3-butyl-1-methylimidazolium
bmim
SCHEMBL34968
AKOS025264493
IQQRAVYLUAZUGX-UHFFFAOYSA-N
1-butyl-3-methyl-imidazolium
3-butyl-1-methyl-1h-imidazol-3-ium
DTXSID6047238
bm0 ,
Q5008232
STL185698

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"This study investigated the cytotoxic, oxidative and genotoxic effects of two commonly used imidazolium ionic liquids (ILs), [bmim][BF4] (1-butyl-3-methylimidazolium) and [omim][BF4] (1-methyl-3-octylimidazolium tetrafluoroborate), on the marine mussel Mytilus galloprovincialis, as well as whether acetone could mediate their toxic profile."( Investigation of toxic effects of imidazolium ionic liquids, [bmim][BF4] and [omim][BF4], on marine mussel Mytilus galloprovincialis with or without the presence of conventional solvents, such as acetone.
Belavgeni, A; Dailianis, S; Tsarpali, V, 2015
)
0.62

Compound-Compound Interactions

ExcerptReferenceRelevance
" The experiments were carried out for 2h using 40 g of supercritical carbon dioxide combined with 1-butyl-3-methylimidazolium acetate and 15."( Supercritical carbon dioxide combined with 1-butyl-3-methylimidazolium acetate and ethanol for the pretreatment and enzymatic hydrolysis of sugarcane bagasse.
Corazza, ML; Ramos, LP; Silveira, MH; Vanelli, BA, 2015
)
0.9

Dosage Studied

ExcerptRelevanceReference
" The effects of ionic liquid kinds, temperature, time, and methanol dosage on methanolysis results of PC were examined."( Environmentally benign methanolysis of polycarbonate to recover bisphenol A and dimethyl carbonate in ionic liquids.
Cui, X; Ge, X; Li, Z; Liu, F; Yu, S, 2010
)
0.36
" The influences of temperature, time, water dosage and [Bmim][Ac] dosage on the hydrolysis reaction were examined."( Hydrolysis of polycarbonate catalyzed by ionic liquid [Bmim][Ac].
Ge, X; Li, L; Liu, F; Song, X; Yang, X; Yu, S, 2013
)
0.39
" The results demonstrated that [Bmim]Im exhibited high activity and the yield of biodiesel was up to 95% or more when molar ratio of methanol to vegetable oil was 6:1, ionic liquid dosage was 6 wt."( Biodiesel production using alkaline ionic liquid and adopted as lubricity additive for low-sulfur diesel fuel.
Fan, W; Li, Y; Luo, H; Nan, G, 2013
)
0.39
"0130 with 5 wt% starch concentration and 1 wt% lipase dosage based on ILs weight at 50 °C for 3h."( Ionic liquids as novel solvents for biosynthesis of octenyl succinic anhydride-modified waxy maize starch.
Li, D; Tian, Y; Zhang, X, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
1-alkyl-3-methylimidazoliumAn imidazolium ion with an alkyl substituent at the 1-position and a methyl substituent at the 3-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency7.94335.623417.292931.6228AID485281
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency22.38720.00798.23321,122.0200AID2551
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (131)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (12.21)29.6817
2010's103 (78.63)24.3611
2020's12 (9.16)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.73 (24.57)
Research Supply Index4.89 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index63.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other132 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]